Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Gonzalez, Luis O ^a,b   Corte, Maria D ^a   Vazquez, Julio ^b,c   Junquera, Sara ^a   Sanchez, Rosario ^a   Alvarez, Ana C ^a,b   Rodriguez, Juan C ^a,b   Lamelas, Maria L ^a,b   Vizoso, Francisco J ^a,b  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL ÁLVAREZ BUYLLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; INTERSTITIAL COLLAGENASE; MATRILYSIN; METALLOPROTEINASE; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SCORING SYSTEM; SURVIVAL TIME; TISSUE MICROARRAY; BIOSYNTHESIS; BREAST TUMOR; GENE EXPRESSION REGULATION; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN MICROARRAY; SURVIVAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; METALLOPROTEASES; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RECEPTORS, ANDROGEN; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 44949129660     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-149     Document Type: Article

References (49)

1. Kuenen-Boumeester V Van der Kwast TH Claassen CC Look MP Liem GS Klijn JG Henzen-Logmans SC The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters Eur J Cancer 1996, 32A(9):1560-1565. 10.1016/ 0959-8049(96)00112-8 8911118
2. Nicolas Diaz-Chico B German Rodriguez F Gonzalez A Ramirez R Bilbao C Cabrera de Leon A Aguirre Jaime A Chirino R Navarro D Diaz-Chico JC Androgens and androgen receptors in breast cancer J Steroid Biochem Mol Biol 2007, 105(1-5):1-15. 10.1016/j.jsbmb.2006.11.019 17631997
3. Lippman M Bolan G Huff K The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture Cancer Res 1976, 36(12):4610-4618. 1000506
4. Dorgan JF Longcope C Stephenson HE Jr. Falk RT Miller R Franz C Kahle L Campbell WS Tangrea JA Schatzkin A Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk Cancer Epidemiol Biomarkers Prev 1996, 5(7):533-539. 8827358
5. Wysowski DK Comstock GW Helsing KJ Lau HL Sex hormone levels in serum in relation to the development of breast cancer Am J Epidemiol 1987, 125(5):791-799 3565354
6. Hankinson SE Willett WC Manson JE Colditz GA Hunter DJ Spiegelman D Barbieri RL Speizer FE Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 1998, 90(17):1292-1299. 10.1093/jnci/90.17.1292 9731736
7. Lillie EO Bernstein L Ursin G The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer Breast Cancer Res 2003, 5(3):164-173. 165007 12793900 10.1186/bcr593
8. Lea OA Kvinnsland S Thorsen T Improved measurement of androgen receptors in human breast cancer Cancer Res 1989, 49(24 Pt 1):7162-7167. 2582456
9. Hall RE Aspinall JO Horsfall DJ Birrell SN Bentel JM Sutherland RL Tilley WD Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer Br J Cancer 1996, 74(8):1175-1180. 8883401
10. Riva C Dainese E Caprara G Rocca PC Massarelli G Tot T Capella C Eusebi V Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma Virchows Arch 2005, 447(4):695-700. 10.1007/s00428-005-0003-6 16075292
11. Miller WR Telford J Dixon JM Hawkins RA Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity Eur J Cancer Clin Oncol 1985, 21(4):539-542. 10.1016/ 0277-5379(85)90049-5 4007019
12. Brentani MM Franco EL Oshima CT Pacheco MM Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach Int J Cancer 1986, 38(5):637-642. 10.1002/ ijc.2910380504 3770993
13. Isola JJ Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors J Pathol 1993, 170(1):31-35. 10.1002/path.1711700106 8100853
14. Moinfar F Okcu M Tsybrovskyy O Regitnig P Lax SF Weybora W Ratschek M Tavassoli FA Denk H Androgen receptors frequently are expressed in breast carcinomas: Potential relevance to new therapeutic strategies Cancer 2003, 98(4):703-711. 10.1002/cncr.11532 12910513
15. Gonzalez LO Pidal I Junquera S Corte MD Vazquez J Rodriguez JC Lamelas ML Merino AM Garcia-Muniz JL Vizoso FJ Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse Br J Cancer 2007, 97(7):957-963. 17848954
16. Agoff SN Swanson PE Linden H Hawes SE Lawton TJ Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations Am J Clin Pathol 2003, 120(5):725-731. 10.1309/42F0-0D0D-JD0J-5EDT 14608899
17. Bieche I Parfait B Tozlu S Lidereau R Vidaud M Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene Carcinogenesis 2001, 22(9):1521-1526. 10.1093/carcin/22.9.1521 11532875
18. Bratthauer GL Lininger RA Man YG Tavassoli FA Androgen and estrogen receptor mRNA status in apocrine carcinomas Diagn Mol Pathol 2002, 11(2):113-118. 10.1097/00019606-200206000-00008 12045715
19. Gatalica Z Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ Pathol Res Pract 1997, 193(11-12):753-758. 9521507
20. Soreide JA Lea OA Varhaug JE Skarstein A Kvinnsland S Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment Eur J Surg Oncol 1992, 18(2):112-118. 1582503
21. Bayer-Garner IB Smoller B Androgen receptors: A marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site Mod Pathol 2000, 13(2):119-122. 10.1038/modpathol.3880021 10697267
22. Nelson AR Fingleton B Rothenberg ML Matrisian LM Matrix metalloproteinases: Biologic activity and clinical implications J Clin Oncol 2000, 18(5):1135-1149. 10694567
23. Pang ST Flores-Morales A Skoog L Chuan YC Nordstedt G Pousette A Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer Oncol Rep 2004, 11(6):1187-1192. 15138554
24. Bryan RM Mercer RJ Bennett RC Rennie GC Lie TH Morgan FJ Androgen receptors in breast cancer Cancer 1984, 54(11):2436-2440. 10.1002/ 1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H 6498736
25. Schippinger W Regitnig P Dandachi N Wernecke KD Bauernhofer T Samonigg H Moinfar F Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer Virchows Arch 2006, 449(1):24-30. 10.1007/s00428-006-0213-6 16628414
26. Elston EW Ellis IO Method for grading breast cancer J Clin Pathol 1993, 46(2):189-190. 501162 8459046 10.1136/jcp.46.2.189-b
27. Parker RL Huntsman DG Lesack DW Cupples JB Grant DR Akbari M Gilks CB Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray Am J Clin Pathol 2002, 117(5):723-728. 10.1309/ PEF8-GL6F-YWMC-AG56 12090420
28. Vizoso FJ Gonzalez LO Corte MD Rodriguez JC Vazquez J Lamelas ML Junquera S Merino AM Garcia-Muniz JL Study of matrix metalloproteinases and their inhibitors in breast cancer Br J Cancer 2007, 96(6):903-911. 10.1038/sj.bjc.6603666 17342087
29. Narita D Raica M Suciu C Cimpean A Anghel A Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer Folia Histochem Cytobiol 2006, 44(3):165-172. 16977795
30. Egeblad M Werb Z New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2002, 2(3):161-174. 10.1038/nrc745 11990853
31. Turk V Kos J Turk B Cysteine cathepsins (proteases) - on the main stage of cancer? Cancer Cell 2004, 5(5):409-410. 10.1016/S1535-6108(04)00117-5 15144947
32. Manes S Llorente M Lacalle RA Gomez-Mouton C Kremer L Mira E Martinez AC The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells J Biol Chem 1999, 274(11):6935-6945. 10.1074/jbc.274.11.6935 10066747
33. Noe V Fingleton B Jacobs K Crawford HC Vermeulen S Steelant W Bruyneel E Matrisian LM Mareel M Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 J Cell Sci 2001, 114(Pt 1);111-118. 11112695
34. Fingleton B Vargo-Gogola T Crawford HC Matrisian LM Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis Neoplasia 2001, 3(6):459-468. 1506562 11774028 10.1038/sj.neo.7900190
35. Stetler-Stevenson WG Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention J Clin Invest 1999, 103(9):1237-1241. 408361 10225966 10.1172/JCI6870
36. Cornelius LA Nehring LC Harding E Bolanowski M Welgus HG Kobayashi DK Pierce RA Shapiro SD Matrix metalloproteinases generate angiostatin: effects on neovascularization J Immunol 1998, 161(12):6845-6852. 9862716
37. Jiang Y Goldberg ID Shi YE Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 2002, 21(14):2245-2252. 10.1038/ sj.onc.1205291 11948407
38. Wurtz SO Schrohl AS Sorensen NM Lademann U Christensen IJ Mouridsen H Brunner N Tissue inhibitor of metalloproteinases-1 in breast cancer Endocr Relat Cancer 2005, 12(2):215-227. 10.1677/erc.1.00719 15947098
39. Gonzalez LO Corte MD Junquera S Bongera M Rodriguez JC Vizoso FJ Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast Histopathology 2007, 50(7):866-874. 10.1111/ j.1365-2559.2007.02687.x 17543076
40. Mitropoulou TN Tzanakakis GN Kletsas D Kalofonos HP Karamanos NK Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells Int J Cancer 2003, 104(2):155-160. 10.1002/ijc.10941 12569569
41. Di GH Lu JS Song CG Li HC Shen ZZ Shao ZM Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas J Exp Clin Cancer Res 2005, 24(4):601-607. 16471323
42. Wilson SR Gallagher S Warpeha K Hawthorne SJ Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors Prostate 2004, 60(2):168-174. 10.1002/ pros.20047 15162383
43. Miyamoto H Altuwaijri S Cai Y Messing EM Chang C Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: Potential therapeutic approaches for prostate cancer Mol Carcinog 2005, 44(1):1-10. 10.1002/mc.20121 16044418
44. Nielsen BS Rank F Lopez JM Balbin M Vizoso F Lund LR Dano K Lopez-Otin C Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas Cancer Res 2001, 61(19);7091-7100. 11585740
45. Schneikert J Peterziel H Defossez PA Klocker H Launoit Y Cato AC Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression J Biol Chem 1996, 271(39):23907-23913. 10.1074/ jbc.271.39.23907 8798622
46. Zhou J Ng S Adesanya-Famuiya O Anderson K Bondy CA Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression Faseb J 2000, 14(12):1725-1730. 10.1096/ fj.99-0863com 10973921
47. Birrell SN Bentel JM Hickey TE Ricciardelli C Weger MA Horsfall DJ Tilley WD Androgens induce divergent proliferative responses in human breast cancer cell lines J Steroid Biochem Mol Biol 1995, 52(5):459-467. 10.1016/0960-0760(95)00005-K 7748811
48. Buchanan G Birrell SN Peters AA Bianco-Miotto T Ramsay K Cops EJ Yang M Harris JM Simila HA Moore NL Bentel JM Ricciardelli C Horsfall DJ Butler LM Tilley WD Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate Cancer Res 2005, 65(18):8487-8496. 10.1158/ 0008-5472.CAN-04-3077 16166329
49. Beilin J Ball EM Favaloro JM Zajac JD Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines J Mol Endocrinol 2000, 25(1):85-96. 10.1677/jme.0.0250085 10915221